Strategic Wealth Partners Ltd. Buys New Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Strategic Wealth Partners Ltd. purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 576 shares of the medical equipment provider's stock, valued at approximately $301,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of ISRG. Merit Financial Group LLC raised its stake in shares of Intuitive Surgical by 49.7% during the fourth quarter. Merit Financial Group LLC now owns 6,664 shares of the medical equipment provider's stock worth $3,478,000 after acquiring an additional 2,213 shares in the last quarter. Sanibel Captiva Trust Company Inc. grew its holdings in shares of Intuitive Surgical by 46.9% during the 4th quarter. Sanibel Captiva Trust Company Inc. now owns 930 shares of the medical equipment provider's stock valued at $485,000 after purchasing an additional 297 shares during the last quarter. Ameritas Advisory Services LLC raised its position in Intuitive Surgical by 24.8% in the 4th quarter. Ameritas Advisory Services LLC now owns 1,628 shares of the medical equipment provider's stock worth $850,000 after purchasing an additional 324 shares during the period. LVW Advisors LLC lifted its stake in Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock worth $756,000 after purchasing an additional 19 shares during the last quarter. Finally, Diversify Wealth Management LLC lifted its stake in Intuitive Surgical by 101.7% in the fourth quarter. Diversify Wealth Management LLC now owns 8,063 shares of the medical equipment provider's stock worth $4,414,000 after purchasing an additional 4,066 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of recent research reports. Erste Group Bank lowered Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. Jefferies Financial Group lifted their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. JPMorgan Chase & Co. increased their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Evercore ISI cut their price target on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a report on Wednesday, April 23rd. Finally, Citigroup upped their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research note on Friday, January 24th. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $598.95.

Insider Buying and Selling

In related news, CFO Jamie Samath sold 188 shares of the company's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $566.94, for a total value of $106,584.72. Following the transaction, the chief financial officer now owns 7,162 shares in the company, valued at $4,060,424.28. The trade was a 2.56% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. This trade represents a 68.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 32,700 shares of company stock worth $16,865,621 in the last 90 days. Insiders own 0.70% of the company's stock.

Intuitive Surgical Trading Down 0.3%

Shares of ISRG stock opened at $561.63 on Tuesday. The company's fifty day moving average price is $506.50 and its 200-day moving average price is $537.23. The stock has a market cap of $201.30 billion, a PE ratio of 87.62, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 12 month low of $395.60 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the previous year, the firm posted $1.50 earnings per share. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.